2022 Annual Meeting | C155 - Movement Disorders: Huntington's Disease

Date Thursday 04/07/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Karen S. Marder, MD, MPH, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants should understand new evidence explaining variable age at onset in Huntington's and implications for genetic testing, apply a multidisciplinary approach to treatment for motor, cognitive, and psychiatric impairments across the lifespan, and critically evaluate pharmacological and nonpharmacological current and future clinical trials in HD.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	What's New in Huntington's Disease Karen S. Marder, MD, MPH, FAAN
07:00 AM - 07:00 AM PDT	Speaker	Walk-in Slides Karen S. Marder, MD, MPH, FAAN
07:05 AM - 07:35 AM PDT	Speaker	Genetic Modifiers of Age at Onset in HD: A Paradigm Shift Suman Jayadev, MD
07:35 AM - 07:40 AM PDT	Q&A	Genetic Modifiers of Age at Onset: A Paradigm Shift Suman Jayadev, MD
07:40 AM - 08:10 AM PDT	Speaker	Multidisciplinary Approach to HD Care Across the Lifespan Lauren Seeberger, MD, FAAN
08:10 AM - 08:15 AM PDT	Q&A	Multidisciplinary Approach to HD Care Across the Lifespan Lauren Seeberger, MD, FAAN
08:15 AM - 08:45 AM PDT	Speaker	Update on Clinical Trials in Huntington's Disease Andrew S. Feigin, MD
08:45 AM - 08:50 AM PDT	Q&A	Update on Clinical Trials in Huntington's Disease Andrew S. Feigin, MD
08:50 AM - 09:00 AM PDT	Q&A	Questions and Answers Karen S. Marder, MD, MPH, FAAN, Lauren Seeberger, MD, FAAN, Andrew S. Feigin, MD

Faculty Disclosures
Karen S. Marder, MD, MPH, FAAN	Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Lauren Seeberger, MD, FAAN	Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocine Biosciences. Dr. Seeberger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. The institution of Dr. Seeberger has received research support from Neurocrine. The institution of Dr. Seeberger has received research support from TEVA.
Andrew S. Feigin, MD	Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Suman Jayadev, MD	Dr. Jayadev has nothing to disclose.